FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty

NCT03276143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

813

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Arthroplasty, Total

Interventions

DRUG: Enoxaparin
DRUG: Apixaban
DRUG: BAY1213790

Sponsor

Bayer